Intriguingly, B-RAF and EPHA2 were not included in our candidate list, because B-RAF did not interact with RNF149 based on our Co-IP experiments, and EPHA2 protein levels did not decrease profoundly when RNF149 was overexpressed, which might be resulting from differences of experimental conditions and cancer cell lines. This evidence concerns the gene EPHA2 and cancer.